GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Solvonis Therapeutics PLC (LSE:SVNS) » Definitions » Market Cap

Solvonis Therapeutics (LSE:SVNS) Market Cap : £3.79 Mil (As of Apr. 08, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Solvonis Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Solvonis Therapeutics's share price for the quarter that ended in Sep. 2024 was £0. Solvonis Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 124.76 Mil. Therefore, Solvonis Therapeutics's market cap for the quarter that ended in Sep. 2024 was £0.00 Mil.

Solvonis Therapeutics's quarterly market cap declined from Dec. 2023 (£0.60 Mil) to Jun. 2024 (£0.53 Mil) and declined from Jun. 2024 (£0.53 Mil) to Sep. 2024 (£0.00 Mil).

Solvonis Therapeutics's annual market cap increased from May. 2021 (£0.00 Mil) to Dec. 2022 (£14.47 Mil) but then declined from Dec. 2022 (£14.47 Mil) to Dec. 2023 (£0.60 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Solvonis Therapeutics's Enterprise Value for Today is £2.85 Mil.


Solvonis Therapeutics Market Cap Historical Data

The historical data trend for Solvonis Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solvonis Therapeutics Market Cap Chart

Solvonis Therapeutics Annual Data
Trend May18 May19 May20 May21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial - - - 14.47 0.60

Solvonis Therapeutics Quarterly Data
May18 May19 May20 May21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.27 - 0.60 0.53 -

Competitive Comparison of Solvonis Therapeutics's Market Cap

For the Specialty Industrial Machinery subindustry, Solvonis Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solvonis Therapeutics's Market Cap Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Solvonis Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Solvonis Therapeutics's Market Cap falls into.


;
;

Solvonis Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Solvonis Therapeutics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=£0.00575*104.097
=£0.60

Solvonis Therapeutics's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=£0*124.764
=£0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solvonis Therapeutics  (LSE:SVNS) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Solvonis Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Solvonis Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Solvonis Therapeutics Business Description

Traded in Other Exchanges
Address
Eccleston Yards, 25 Eccleston Place, London, GBR, SW1W 9NF
Solvonis Therapeutics PLC, formerly Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end-use markets, from automotive through to medical, and are not dependent on one market segment. The Company operates in two business segments being polymer development and production in Slovenia.

Solvonis Therapeutics Headlines

No Headlines